Kerendia (Finerenone)

Kerendia is a non-steroidal mineralocorticoid receptor antagonist (MRA) used to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospital stay for heart failure in adult individuals with chronic kidney disease associated with type 2 diabetes (T2D).

Recommended Dosage: The recommended starting dosage of Kerendia tablets is 10 mg or 20 mg orally once daily with or without food on behalf of estimated glomerular filtration rate (eGFR) and serum potassium thresholds. Kerendia dosage can be scaled up after four weeks to the target dose of 20 mg once daily, on behalf of estimated Glomerular Filtration Rate (eGFR) and serum potassium thresholds.

Those who are not capable of swallowing whole tablets, Kerendia may be crushed and mixed with water promptly prior to use and administered orally.

In case of a missed dose, the prescribed dose should be taken as quickly as possible before the very next scheduled dose. Do not take a couple of doses on the very same day to catch up for a missed dose.

• Measure serum potassium 4 weeks after initiating therapy and adjust dose; if serum potassium levels are > 4.8 to 5.0 mEq/L, initiation of Kerendia therapy may be considered with additional serum potassium monitoring within the initial 4 weeks on behalf of clinical judgment and serum potassium levels. Assess serum potassium 4 weeks following a dose adjustment and throughout therapy, and adjust the dose as required.
• Kerendia can be responsible for causing hyperkalemia. The chance of occurring hyperkalemia scales up with scaling down kidney function and is higher in all those with greater baseline potassium levels or certain other risk factors for hyperkalemia. Measure serum potassium and eGFR in all those prior to initiation of Kerendia 20 mg treatment and dose accordingly.
• The concomitant consumption of grapefruit or grapefruit juice needs to be avoided as it may be responsible for enhancing the plasma concentration of medicine finerenone.
• Prior to taking Kerendia, patients should inform their health specialist in case they are pregnant or want to become pregnant. Breastfeeding is not recommended at the time of treatment with Finerenone and for 24 hours after treatment.

Indian Pharma Network is able to source the KERENDIA (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma Network offers its customers worldwide access to the best available treatment.

Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Kerendia®?

Finerenone is a Generic Name for the trade name drug Kerendia®.

What is the Manufacturer’s Name of Kerendia®?

Kerendia® is manufactured by Bayer HealthCare Pharmaceuticals Inc. 

Is Kerendia® approved by the FDA?

Yes, Kerendia® is approved by the FDA. Date of first/initial approval: July 13, 2021.

What is the dosage and form of Kerendia® supplied?

Kerendia® is supplied as a film-coated tablet in two strengths 10 mg and 20 mg for oral administration.

What are the most common side effects of Kerendia®? 

The most common side effects of Kerendia® are hypotension, hyperkalemia, and hyponatremia.

How much does Kerendia® cost in India?

The kerendia cost in India can vary. In order to procure this CKD associated with T2D drug authentically, you can Call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

What are the storage conditions of Kerendia®?

Kerendia 10 mg/20 mg comes in bottles of 30 and 90 pills. Store tablets at 20-25°C (68-77°F); excursions are permitted from 15-30°C (59-86°F).

Is it safe to buy Kerendia® online in India?

Yes, you can buy kerendia in India at the best price from the Indian Pharma Network (IPN) if Kerendia has not been approved or is not available in your home country.

What are the Highlights of prescribing information for Kerendia®?

Click Here to download full  Kerendia prescribing information.